Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
100% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2005 | 2016 | 2017 | |
|---|---|---|---|
| Revenue | $362.1K | $3.6M | $2.8M |
| Cost of revenue | $557.9K | $2.0M | $1.1M |
| Gross profit | −$195.8K | $1.7M | $1.8M |
| Gross margin | -54.1% | 45.7% | 62.4% |
| R&D | $0 | $0 | $0 |
| Operating income | −$641.4K | $10.4K | $438.2K |
| EBITDA | −$385.7K | $32.3K | $456.1K |
| Net income | −$627.3K | $5.7K | $394.8K |
| Net margin | -173.3% | 0.2% | 14.0% |
| EPS (diluted) | -0.03 | 0.00 | 0.02 |
Annual figures · source: Financial Modeling Prep
MEDICAL SUPPLY INTL USA
No one on the platform currently holds MSIU.
No tracked institution reports a position in MSIU as of their last filing.
| Execution date | Ratio |
|---|---|
| 2018-11-02 | 1-for-20reverse |
No one on the platform has traded MSIU yet.
| $2M |
| — |
| LVRLFCordovaCann Corp. | $0.04 | +0.00% | $4M | — |
| PBIOPressure BioSciences, Inc. | $0.00 | +0.00% | $28677 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.